Status:
COMPLETED
Trial of IC351 in Female Scleroderma Patients With Raynaud's and Sexual Dysfunction
Lead Sponsor:
University of Medicine and Dentistry of New Jersey
Conditions:
Systemic Sclerosis
Eligibility:
FEMALE
18+ years
Phase:
PHASE2
Brief Summary
Purpose of the study is to evaluate the effectiveness and safety of a new investigational dur, IC351. Study is designed to gather information regarding the possible usefulness of IC351 as a treatment ...
Eligibility Criteria
Inclusion
- Female with diagnosis of scleroderma
- Stable sexual relationship with male partner or be sexually active
- Raynaud phenomenon at least 6 times per week
- Willing to attempt sexual activity 1/month during study period
Exclusion
- Severe internal organ problems related to scleroderma
- Other gynecologic problems
- Serious depression
- Receiving other experimental and Raynaud treatments
Key Trial Info
Start Date :
July 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2002
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00707187
Start Date
July 1 2001
End Date
July 1 2002
Last Update
June 30 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UMDNJ
New Brunswick, New Jersey, United States, 08903